{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:13:39Z","timestamp":1787775219267,"version":"build-2784847793"},"reference-count":24,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.oret.2025.03.027","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T16:57:04Z","timestamp":1744304224000},"page":"964-971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Long-Term Effects of Anti-VEGF Therapy versus Panretinal Photocoagulation on Retinal Vessel Caliber in Eyes with Proliferative Diabetic Retinopathy"],"prefix":"10.1016","volume":"9","author":[{"given":"Steven","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Josic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8564-6537","authenticated-orcid":false,"given":"Jeong W.","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5484-2535","authenticated-orcid":false,"given":"Stacy M.","family":"Meuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2011-3833","authenticated-orcid":false,"given":"Michele","family":"Melia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitha","family":"Domalpally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Blodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2025.03.027_bib1","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/jama.2015.15217","article-title":"Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial","volume":"314","author":"Writing Committee for the Diabetic Retinopathy Clinical Research Network","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.oret.2025.03.027_bib2","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/jamaophthalmol.2018.3255","article-title":"Five-year outcomes of panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial","volume":"136","author":"Gross","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.027_bib3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1755-3768.1994.tb07180.x","article-title":"Visual fields at different stages of diabetic retinopathy","volume":"72","author":"Henricsson","year":"1994","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.027_bib4","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/bjo.77.11.726","article-title":"Visual field loss with capillary non-perfusion in preproliferative and early proliferative diabetic retinopathy","volume":"77","author":"Chee","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.027_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41433-021-01649-0","article-title":"Retinal non-perfusion in diabetic retinopathy","volume":"36","author":"Wykoff","year":"2022","journal-title":"Eye"},{"key":"10.1016\/j.oret.2025.03.027_bib6","article-title":"Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy","volume":"2","author":"Perais","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.oret.2025.03.027_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archophthalmol.2010.347","article-title":"Retinal vessel diameter as a clinical predictor of diabetic retinopathy progression: time to take out the measuring tape","volume":"129","author":"Wong","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.027_bib8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/archopht.122.1.76","article-title":"The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: the Wisconsin epidemiologic study of diabetic retinopathy","volume":"122","author":"Klein","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.027_bib9","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.oret.2020.09.003","article-title":"Retinal vascular caliber association with nonperfusion and diabetic retinopathy severity depends on vascular caliber measurement location","volume":"5","author":"Ashraf","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2025.03.027_bib10","doi-asserted-by":"crossref","first-page":"8558","DOI":"10.1167\/iovs.11-7917","article-title":"Suboptimal image focus broadens retinal vessel caliber measurement","volume":"5","author":"Chandler","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2025.03.027_bib11","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/S0161-6420(99)90525-0","article-title":"Methods for evaluation of retinal microvascular abnormalities associated with hypertension\/sclerosis in the Atherosclerosis Risk in Communities Study","volume":"106","author":"Hubbard","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.03.027_bib12","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1167\/iovs.03-0079","article-title":"Retinal vessel diameters and their associations with age and blood pressure","volume":"44","author":"Wong","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2025.03.027_bib13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1442-9071.2002.00520.x","article-title":"Reliability of computer-assisted retinal vessel measurement in a population","volume":"3","author":"Sherry","year":"2002","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.027_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1076\/ceyr.27.3.143.16049","article-title":"Revised formulas for summarizing retinal vessel diameters","volume":"2","author":"Knudtson","year":"2003","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.oret.2025.03.027_bib15","first-page":"22","article-title":"Relationship between retinal vessel diameters and retinopathy in the Inter99 Eye Study","volume":"8","author":"Drobnjak","year":"2017","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.oret.2025.03.027_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-017-0909-9","article-title":"Diameter changes of retinal vessels in diabetic retinopathy","volume":"17","author":"Bek","year":"2017","journal-title":"Curr Diabetes Rep"},{"key":"10.1016\/j.oret.2025.03.027_bib17","first-page":"749","article-title":"Changes in retinal vessel diameter and incidence and progression of diabetic retinopathy","volume":"13","author":"Klein","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.027_bib18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0002-9394(88)90823-9","article-title":"Optic disk neovascularization and retinal vessel diameter in diabetic retinopathy","volume":"106","author":"Wilson","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.027_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/archopht.123.5.709-a","article-title":"Retinal vessel caliber and diabetic retinopathy","volume":"123","author":"Stefansson","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.027_bib20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0002-9394(14)73526-3","article-title":"Retinal vasoconstriction after laser treatment for diabetic macular edema","volume":"115","author":"Gottfredsd\u00f3ttir","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.027_bib21","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/eye.2014.186","article-title":"Association of retinal vessel calibre and visual outcome in eyes with diabetic macular oedema treated with ranibizumab","volume":"28","author":"Moradi","year":"2014","journal-title":"Eye"},{"key":"10.1016\/j.oret.2025.03.027_bib22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/aos.14278","article-title":"Alterations in retinal arteriolar microvascular structure associate with higher treatment burden in patients with diabetic macular oedema: results from a 12-month prospective clinical trial","volume":"98","author":"Blindb\u00e6k","year":"2020","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.027_bib23","article-title":"Retinal vein changes after treatment with aflibercept and PRP in high-risk proliferative diabetic retinopathy","volume":"10","author":"Zhao","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.oret.2025.03.027_bib24","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s41433-021-01750-4","article-title":"Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy","volume":"36","author":"Chatziralli","year":"2022","journal-title":"Eye"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025001599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025001599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:29:47Z","timestamp":1759343387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653025001599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2468653025001599"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2025.03.027","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Effects of Anti-VEGF Therapy versus Panretinal Photocoagulation on Retinal Vessel Caliber in Eyes with Proliferative Diabetic Retinopathy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2025.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}